{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "POSTPOST", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.13, "exchange": "PAR", "shortName": "PHERECYDES PHARMA S.A.", "longName": "Pherecydes Pharma Soci\u00e9t\u00e9 anonyme", "messageBoardId": "finmb_252792572", "exchangeTimezoneName": "Europe/Paris", "market": "fr_market", "regularMarketTime": 1683905705, "regularMarketDayHigh": 2.32, "regularMarketDayRange": "2.13 - 2.32", "regularMarketDayLow": 2.13, "regularMarketVolume": 30372, "regularMarketPreviousClose": 2.13, "fullExchangeName": "Paris", "financialCurrency": "EUR", "regularMarketOpen": 2.32, "averageDailyVolume3Month": 8055, "averageDailyVolume10Day": 6561, "fiftyTwoWeekLowChange": 0.2700001, "fiftyTwoWeekLowChangePercent": 0.14516135, "fiftyTwoWeekRange": "1.86 - 5.0", "fiftyTwoWeekHighChange": -2.87, "fiftyTwoWeekHighChangePercent": -0.574, "fiftyTwoWeekLow": 1.86, "fiftyTwoWeekHigh": 5.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.67, "sharesOutstanding": 7199420, "bookValue": 1.411, "fiftyDayAverage": 2.5422, "fiftyDayAverageChange": -0.41219997, "fiftyDayAverageChangePercent": -0.162143, "twoHundredDayAverage": 2.44028, "twoHundredDayAverageChange": -0.31027985, "twoHundredDayAverageChangePercent": -0.12714928, "marketCap": 16918634, "priceToBook": 1.5095677, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Pherecydes Pharma SA", "nameChangeDate": "2023-05-11", "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1612512000000, "priceHint": 4, "regularMarketChange": 0.0, "symbol": "ALPHE.PA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "102 avenue Gaston Roussel", "city": "Romainville", "zip": "93230", "country": "France", "phone": "33 1 48 40 65 35", "website": "https://www.pherecydes-pharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pherecydes Pharma Soci\u00e9t\u00e9 anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-staphylococcus aureus for the treatment of bone/joint and diabetic foot ulcer infections; anti-pseudomonas aeruginosa, a phage therapy treatment for respiratory tract infections; and anti-escherichia coli for the treatment of respiratory tract infections. The company was founded in 2006 and is headquartered in Romainville, France.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thibaut du Fayet", "age": 54, "title": "Chief Exec. Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pascal  Birman", "title": "C.M.O", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}